Understanding AOD-9604 and Its Research Applications
AOD-9604 is a synthetic peptide fragment derived from the C-terminus of human growth hormone (hGH), encompassing amino acids 177–191. Its structure corresponds to the lipolytic region of the native hormone, which has drawn sustained interest from research institutions investigating lipid metabolism and adipose tissue biology. Unlike the full-length hGH protein, AOD-9604 does not exhibit the same pattern of receptor binding, a feature that makes it a valuable tool for differentiating hormone-mediated signaling pathways in laboratory models.
In cell culture and ex vivo adipose tissue assays, researchers examine how this peptide influences lipolysis, fatty acid oxidation, and the expression of genes associated with lipid storage. Multiple peer-reviewed studies have described its interaction with the β3-adrenergic receptor and downstream cAMP-dependent cascades, providing mechanistic insights without any suggestion of human or veterinary application. Experiments often utilize 3T3-L1 preadipocyte differentiation models to quantify triglyceride accumulation and adipokine secretion profiles. Such work is strictly exploratory, aiming to map metabolic pathways that may have relevance to fundamental biology.
Because AOD-9604 is a synthetic construct, its supply for research requires a high degree of chemical and stereochemical fidelity. Laboratories across academic and pharmaceutical sectors rely on consistent, well-characterized material to ensure reproducibility. The peptide is typically handled as a lyophilized powder, stored at -20°C, and reconstituted in appropriate buffers under sterile conditions. No therapeutic claims attend these applications; rather, the compound serves as a molecular probe in preclinical investigation.
Why GMP Certification Matters for Research-Grade Peptides
Good Manufacturing Practice (GMP) represents a system of production standards enforced by regulatory bodies such as the U.S. Food and Drug Administration, the European Medicines Agency, and Australia’s Therapeutic Goods Administration. For an AOD-9604 GMP manufacturer, adherence to these principles signifies that every step — from raw material acquisition through synthesis, purification, and final packaging — follows documented, validated procedures. In a research context, this level of control is directly linked to experimental reliability.
Peptides obtained from a GMP-compliant source present minimal batch-to-batch variability in purity, residual solvent profile, and counter-ion content. This consistency is critical when replicating dose-response curves, cellular assays, or animal model studies. A deviation of even a few percent in purity or the presence of a minor sequence isomer can confound data interpretation and waste research resources. GMP facilities implement stringent vendor qualification for starting materials, in-process controls, and environmental monitoring, all of which contribute to a product that meets predetermined specifications release after release.
Furthermore, GMP certification is increasingly a prerequisite for research organizations that may later transition findings into regulated environments. Although the peptide is solely for laboratory use, the procurement of GMP material supports robust record-keeping and method validation. Customers ranging from university core facilities to large pharmaceutical companies frequently specify GMP-grade peptides to align with internal quality management systems and to satisfy grant or publication requirements.
Key Quality Control Parameters in AOD-9604 Manufacturing
A competent AOD-9604 GMP manufacturer will subject every lot to a panel of analytical tests that confirm identity, purity, and safety attributes critical for research integrity. The core analyses include:
- High-Performance Liquid Chromatography (HPLC): Typically, the purity threshold is set at ≥95%, with many manufacturers achieving >98% as measured by reverse-phase HPLC at 214 nm. The chromatogram verifies that related substances, deletion sequences, or oxidation byproducts remain below acceptable limits, ensuring that the principal peak represents the target peptide.
- 质谱（MS）： Electrospray ionization or MALDI-TOF mass spectrometry confirms the molecular weight within a narrow mass error (e.g., ±1.0 Da). The observed m/z values must match the theoretical monoisotopic mass of the AOD-9604 sequence, confirming sequence integrity and absence of truncation.
- Endotoxin Testing: Bacterial endotoxin levels are determined by the Limulus Amebocyte Lysate (LAL) assay per harmonized pharmacopoeial methods (USP ). Research-grade peptides intended for cell-based assays require a low endotoxin specification, commonly <1.0 EU/mg, to avoid interference with cellular responses.
- Bioburden and Heavy Metals: Microbial enumeration tests and heavy metal analysis (per USP or equivalent) provide additional safety margins. While not intended for human use, these tests indicate process cleanliness and chemical purity.
Additional characterization often includes amino acid analysis, peptide content determination, and counter-ion quantification (e.g., trifluoroacetate or acetate) to give the researcher a complete picture of the material being handled. A comprehensive Certificate of Analysis (CoA) summarizes these results for each batch.
Traceability and Documentation for Regulatory Compliance
Institutional procurement offices and principal investigators depend on a transparent supply chain. A GMP manufacturer issues a complete batch record that links each production run to specific raw material lots, equipment cleaning logs, and analyst sign-offs. This documentation establishes unbroken traceability from the synthesis resin to the sealed vial.
- Batch Records and CoA: Each shipment is accompanied by a CoA that reports the actual test results, not merely typical values. Researchers can reference the unique batch number in their laboratory notebooks, providing an audit trail that satisfies peer reviewers and regulatory inspectors should the data ever be submitted to an authority.
- Supply Chain Audits: Pharmaceutical companies and contract research organizations often conduct on-site audits of their peptide suppliers. A AOD-9604 GMP manufacturer should be able to demonstrate compliance with ICH Q7 guidelines for active pharmaceutical ingredients, even when the product is labeled for research only. Third-party certification bodies (e.g., SGS, TÜV) may also audit the facility.
- Import/Export Compliance: For international distribution, a compliant manufacturer provides documentation such as a Material Safety Data Sheet (MSDS), a declaration of non-hazardous material, and statements regarding the product’s research-only status. Customs clearance for peptides often requires a clear description of the chemical’s identity, quantity, and intended use.
Regulatory authorities in multiple jurisdictions have increased scrutiny of chemical imports. By partnering with a manufacturer that maintains full documentation, research organizations can reduce the risk of shipment delays or customs holds.
Selecting a GMP Manufacturer for AOD-9604
Choosing a reliable supplier involves more than comparing prices per milligram. Researchers and sourcing managers should evaluate the manufacturer’s credentials, production capabilities, and logistical expertise.
- Verify GMP Certification: Request a copy of the current GMP certificate and note the issuing body. Certificates from national authorities such as the FDA (USA), MHRA (UK), or TGA (Australia) carry more weight than self-declarations. Confirm that the certificate covers the specific facility and the type of manufacturing activities (e.g., solid-phase peptide synthesis, lyophilization, sterile filtration).
- Assess Production Scale: AOD-9604 is often needed in quantities ranging from 10 mg for initial in vitro experiments to multiple grams for sustained animal studies. A capable AOD-9604 GMP manufacturer should offer flexible scales with confirmed capacity. Ask about typical lead times, minimum order quantities, and whether the manufacturer can provide a reference standard upon request.
- Evaluate Logistics and Cold Chain: Peptides are hygroscopic and susceptible to degradation when exposed to moisture or elevated temperatures. The manufacturer should ship lyophilized AOD-9604 in airtight, light-protected vials with temperature control (e.g., cold packs or dry ice for frozen liquid formulations). Delivery times and customs clearance support become critical when research timelines are tight.
- Customer Support and Technical Expertise: A knowledgeable technical team can advise on solubility, storage conditions, and proper handling without crossing into recommendations for human use. Prompt responses to inquiries about CoA data or shipping documentation indicate a professionally managed operation.
Many research buyers also consider the manufacturer’s history with similar peptide products. A supplier that routinely synthesizes hGH fragments and has published application notes or analytical data online (without promotional medical claims) often understands the nuances of peptide aggregation and oxidation that can affect experimental outcomes.
Frequently Asked Questions About AOD-9604 Supply
Is AOD-9604 the same as HGH fragment?
Yes. AOD-9604 corresponds specifically to the 177–191 fragment of the human growth hormone polypeptide. It is a discrete synthetic entity and should not be confused with full-length hGH or other fragments such as AOD-9401 (176–191). Researchers select it for its distinct sequence and biological profile in laboratory models.
What is the typical purity for research-grade AOD-9604?
Most published studies and institutional protocols require a purity of ≥95% as determined by HPLC. A AOD-9604 GMP manufacturer will typically deliver material at 96–99% purity, with full analytical characterization provided per batch. Higher purity minimizes the risk of off-target effects in sensitive assays.
Can I request custom packaging or labeling?
Many GMP manufacturers offer custom packaging options for research laboratories, such as vials with specific fill weights, amber glass containers for light-sensitive protocols, or labeling that includes the lab’s project code. Customization usually requires a minimum order size and an agreement on lead time. Requests should always remain within the framework of research-only use.
Are there any restrictions on ordering AOD-9604 for research?
In most jurisdictions, AOD-9604 is not classified as a controlled substance, but import regulations vary by country. Researchers should verify that their institution holds the necessary permits for peptide importation and that the intended experiments comply with local biosafety and ethics committee approvals. A compliant manufacturer will not ship to individuals or entities that suggest any intention for human or veterinary application.
How should AOD-9604 be stored upon receipt?
Lyophilized AOD-9604 should be stored at -20°C in a desiccated environment, protected from light. Once reconstituted, the stock solution is typically aliquoted and kept at -20°C or -80°C to avoid repeated freeze-thaw cycles. The CoA and manufacturer’s handling guide provide specific recommendations based on stability studies conducted under controlled conditions.
Research use only: All information and products discussed herein are exclusively for laboratory research purposes. They are not intended for use in humans or animals for any diagnostic, preventative, or other application. Statements have not been evaluated by any regulatory health authority. Buyers assume full responsibility for compliance with applicable laws and institutional guidelines.
仅限研究用途。不得用于人类或兽医用途。.
